IDEA Center-backed startup engineers T-cells to reduce risk of adverse side effects of cancer treatment // News // IDEA Center // University of Notre Dame
Researchers identify 'switch' to activate can | EurekAlert!
Tumor-associated Antigens | TCI AMERICA
Cancer vaccines: shared tumor antigens return to the spotlight | Signal Transduction and Targeted Therapy
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Cancers | Free Full-Text | Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process
Cell-based Immunotherapy | Lonza
Cancer Antigen 27.29 Test: Uses, Procedure, Results
Tumor Intrinsic
Tumor Antigens Resulting from Mutations - LifeTein Cancer Peptides
Table 4 from State of the Art in Tumor Antigen and Biomarker Discovery | Semantic Scholar
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion | Nature Reviews Cancer